A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation.
Fletcher A, Clift D, de Vries E, Martinez Cuesta S, Malcolm T, Meghini F, Chaerkady R, Wang J, Chiang A, Weng SHS, Tart J, Wong E, Donohoe G, Rawlins P, Gordon E, Taylor JD, James L, Hunt J.
Fletcher A, et al. Among authors: taylor jd.
Nat Commun. 2023 Nov 4;14(1):7093. doi: 10.1038/s41467-023-42546-2.
Nat Commun. 2023.
PMID: 37925433
Free PMC article.